Pod 367 - How medical cannabis is driving pediatric epilepsy research
Business of Cannabis was the Platinum Media Partner for the Lift&Co. Expo in Toronto in November 2021. During the show, the Business of Cannabis team sat down with key leaders in the cannabis sector for conversations about where the industry is right now. This conversation was part of those sessions. Dr. Evan Cole Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), teleneurology and medical cannabis for the treatment of neurologic disorders. Dr. Lewis is the director of the Neurology Centre of Toronto (NCT) which he established in January 2017. At NCT, Dr. Lewis treats children with a variety of neurological disorders and he also treats adults for concussion, headache and epilepsy. Dr. Lewis’ interest in medical cannabis began in 2013 while training at Miami Children’s Hospital – one of the major sites for the Epidiolex trials. He has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), Canadian Childhood Cannabinoid Clinical Trials (C4T), and the Cannabinoid Research Initiative of Saskatchewan (CRIS). BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.
Business of Cannabis: Cannabis News | Cannabis Views | Cannabis Trends · Jay Rosenthal, Evan Lewis
Audio is streamed directly from the publisher (chrt.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Business of Cannabis was the Platinum Media Partner for the Lift&Co. Expo in Toronto in November 2021. During the show, the Business of Cannabis team sat down with key leaders in the cannabis sector for conversations about where the industry is right now. This conversation was part of those sessions.
Dr. Evan Cole Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), teleneurology and medical cannabis for the treatment of neurologic disorders. Dr. Lewis is the director of the Neurology Centre of Toronto (NCT) which he established in January 2017. At NCT, Dr. Lewis treats children with a variety of neurological disorders and he also treats adults for concussion, headache and epilepsy. Dr. Lewis’ interest in medical cannabis began in 2013 while training at Miami Children’s Hospital – one of the major sites for the Epidiolex trials. He has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), Canadian Childhood Cannabinoid Clinical Trials (C4T), and the Cannabinoid Research Initiative of Saskatchewan (CRIS).
BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.